Split GFP Labeling of scFvs 29. Cabantous S, Waldo GS (2006) In vivo and in vitro protein solubility assays using split GFP. Nat Methods 3: 845–854. 30. Listwan P, Terwilliger TC, Waldo GS (2009) Automated, high-throughput platform for protein solubility screening using a split-GFP system. J Struct Funct Genomics 10: 47–55. 31. Cabantous S, Pedelacq JD, Mark BL, Naranjo C, Terwilliger TC, et al. (2005) Recent advances in GFP folding reporter and split-GFP solubility reporter technologies. Application to improving the folding and solubility of recalcitrant proteins from Mycobacterium tuberculosis. J Struct Funct Genomics 6: 113–119. 32. Kaddoum L, Magdeleine E, Waldo G, Joly E, Cabantous S (2010) One-step split GFP staining for sensitive protein detection and localization in mammalian cells. Biotechniques 49: 727–736. 33. Listwan P, Pedelacq JD, Lockard M, Bell C, Terwilliger TC, et al. (2010) The optimization of in vitro high-throughput chemical lysis of Escherichia coli. Application to ACP domain of the polyketide synthase ppsC from Mycobac- terium tuberculosis. J Struct Funct Genomics 11: 41–49. 34. VanAntwerp JJ, Wittrup KD (1998) Thermodynamic characterization of affinity maturation: the D1.3 antibody and a higher-affinity mutant. Journal of molecular recognition : JMR 11: 10–13. 35. Oi VT, Glazer AN, Stryer L (1982) Fluorescent phycobiliprotein conjugates for analyses of cells and molecules. The Journal of cell biology 93: 981–986. 36. Chang WR, Jiang T, Wan ZL, Zhang JP, Yang ZX, et al. (1996) Crystal structure of R-phycoerythrin from Polysiphonia urceolata at 2.8 A resolution. Journal of molecular biology 262: 721–731. 37. Hawkins RE, Russell SJ, Baier M, Winter G (1993) The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme. J Mol Biol 234: 958–964. 38. Neri D, Momo M, Prospero T, Winter G (1995) High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J Mol Biol 246: 367–373. 39. Foote J, Winter G (1992) Antibody framework residues affecting the conformation of the hypervariable loops. Journal of molecular biology 224: 487–499. 40. Harper M, Lema F, Boulot G, Poljak RJ (1987) Antigen specificity and cross- reactivity of monoclonal anti-lysozyme antibodies. Molecular immunology 24: 97–108. 41. England P, Nageotte R, Renard M, Page AL, Bedouelle H (1999) Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme. Journal of immunology 162: 2129–2136. 42. Reimann KA, Waite BC, Lee-Parritz DE, Lin W, Uchanska-Ziegler B, et al. (1994) Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry 17: 102–108. 43. Wingren C, Ingvarsson J, Dexlin L, Szul D, Borrebaeck CA (2007) Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support. Proteomics 7: 3055–3065. 44. Griep RA, van Twisk C, van der Wolf JM, Schots A (1999) Fluobodies: green fluorescent single-chain Fv fusion proteins. J Immunol Methods 230: 121–130. 45. Morino K, Katsumi H, Akahori Y, Iba Y, Shinohara M, et al. (2001) Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression. J Immunol Methods 257: 175–184. 46. Nizak C, Monier S, del Nery E, Moutel S, Goud B, et al. (2003) Recombinant antibodies to the small GTPase Rab6 as conformation sensors. Science 300: 984–987. 47. Pavoor TV, Cho YK, Shusta EV (2009) Development of GFP-based biosensors possessing the binding properties of antibodies. Proc Natl Acad Sci U S A. PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e25727